- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05472584
Spinal Cord Stimulation and Training
March 31, 2026 updated by: Ismael Seáñez, Washington University School of Medicine
Neural Plasticity by Spinal Cord Stimulation and Training in People With Spinal Cord Injury
This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The goal of this project is to determine the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal, and spinal neural circuits that are involved in SCS-mediated motor function improvements in individuals with spinal cord injury (SCI).
The study will: (1) Determine the short-term effects in neural excitability induced by SCS and activity-based training.
(2) Determine the effect of motor training on short-term changes in neural excitability enabled by SCS.
(3) Determine the long-term changes in motor control and neural plasticity induced by combined SCS and activity-based training in individuals with chronic SCI.
Having a better understanding of the neural mechanisms that are enhanced by SCS can allow the development of therapies that directly target the excitability and plasticity states of these structures towards improved and accelerated recovery.
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ismael Seanez, PHD
- Phone Number: 314-935-7665
- Email: ismaelseanez@wustl.edu
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63130
- Recruiting
- Washington University
-
Contact:
- Ismael Seanez, PHD
- Phone Number: 314-935-7665
- Email: ismaelseanez@wustl.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Healthy Volunteers
- Age between 16 and 65 years old
- Healthy people with no major comorbidities of any organ system
Exclusion Criteria:
Healthy Volunteers
- Subjects younger than 16 or older than 65 years old
- Subjects not providing consent or not able to consent
- Subjects with any acute or chronic pain condition
- Subjects with any acute or chronic disease of a major organ system
- Use of analgesics within 24 hours prior to study period
- Use of caffeine with 3 hours of study appointment
Inclusion criteria:
Participants with spinal cord injury (SCI)
- Age between 16-65 years old
- Traumatic SCI C4-T9 level, incomplete (ASIA C or D)
- at least 1 year post injury
- Stable medical condition
- difficulty independently performing leg movements in routine activities
- able to follow simple commands
- able to speak and respond to questions
Exclusion criteria:
Participants with spinal cord injury (SCI)
- Subjects younger than 16 or older than 65 years old
- Not willing or able to provide consent
- Any acute or chronic pain condition
- Any acute or chronic disease of a major organ system
- Use of analgesics within 24 hours prior to study appointment
- Use of caffeine with 3 hours of study appointment
- Presence of tremors, spasms and other significant involuntary movements
- Etiology of SCI other than trauma
- Concomitant neurologic disease traumatic brain injury (TBI) that will significantly impact the ability to follow through on study directions, multiple sclerosis (MS), stroke or peripheral neuropathy)
- History of significant medical illness (cardiovascular disease, uncontrolled diabetes, uncontrolled hypertension, osteoporosis, cancer, chronic obstructive pulmonary disease, severe asthma requiring hospitalization for treatment, renal insufficiency requiring dialysis, autonomic dysreflexia, etc).
- Severe joint contractures disabling or restricting lower limb movements.
- Unhealed fracture, contracture, pressure sore, urinary tract infection or other uncontrolled infections, other illnesses that might interfere with lower extremity exercises or testing activities
- Depression, anxiety, or cognitive impairment
- Deficit of visuospatial orientation
- Sitting tolerance less than 1 hour
- Severe hearing or visual deficiency
- Miss more than 3 appointments without notification
- Unable to comply with any of the procedures in the protocol
- Botulinum toxin injection in lower extremity muscles in the prior six months
- Any passive implants (osteosynthesis material, metallic plates or screws) below T9.
- Any implanted stimulator in the body (pacemaker, vagus nerve stimulator, etc.)
- History of alcoholism or another drug abuse
- Pregnancy (or possible pregnancy)
- Having an Intrathecal Baclofen Therapy Pump (ITB pump)
- History of epilepsy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: Non-invasive spinal cord stimulation
This arm will receive 30 minutes of transcutaneous spinal cord stimulation as participants rest.
|
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
|
|
Experimental: Experimental: Activity-based training
This arm will perform 30 minutes of activity-based training using leg movements.
|
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Motor task
|
|
Experimental: Experimental: Activity-based training wtih non-invasive spinal cord stimulation
This arm will receive transcutaneous spinal cord stimulation as participants perform 30 minutes of activity-based training using leg movements.
|
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
|
|
Experimental: Experimental: Non-invasive spinal cord stimulation and strength training
This arm will receive transcutaneous spinal cord stimulation as participants perform strengthening exercises.
|
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
|
|
Experimental: Experimental: Non-invasive spinal cord stimulation and precision training
This arm will receive transcutaneous spinal cord stimulation as participants perform precision-control and dexterity exercises.
|
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
|
|
Experimental: Experimental: Long-term activity-based training with non-invasive spinal cord stimulation
This arm will receive 4 weeks of activity-based training with transcutaneous spinal cord stimulation
|
Kinematics and cortical spinal motor excitability
Kinematics and reticular spinal motor excitability
Kinematics and spinal motoneuron excitability
Non-invasive spinal cord stimulation
Motor task
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor evoked potentials amplitude and latency
Time Frame: 30 minutes before and 30 minutes after intervention; 4 weeks
|
This primary outcome is a measure of changes in corticospinal tract excitability and plasticity as quantified by changes in the amplitude size and onset latency of motor evoked potentials elicited via transcranial magnetic stimulation.
|
30 minutes before and 30 minutes after intervention; 4 weeks
|
|
Reaction time to startle response
Time Frame: 30 minutes before and 30 minutes after intervention; 4 weeks
|
This primary outcome is a measure of changes in reticulospinal tract excitability after training as quantified by changes in reaction time after a startling auditory stimulus.
|
30 minutes before and 30 minutes after intervention; 4 weeks
|
|
F-wave response persistence
Time Frame: 30 minutes before and 30 minutes after intervention; 4 weeks
|
This primary outcome is a measure of changes in spinal motoneuron excitability as quantified by changes in the persistence of F-wave responses elicited via peripheral nerve stimulation.
|
30 minutes before and 30 minutes after intervention; 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in time to completion from baseline
Time Frame: Baseline, 30 minutes, and 4 weeks
|
Participants will perform cursor control as a computer game.
This outcome measure is the time it takes participants to complete each task.
|
Baseline, 30 minutes, and 4 weeks
|
|
Change in movement smoothness
Time Frame: Baseline, 30 minutes, and 4 weeks
|
This outcome is a measure of changes in movement smoothness when operating the computer cursor with the body.
|
Baseline, 30 minutes, and 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ismael Seanez, PhD, Washington University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 21, 2023
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
July 8, 2022
First Submitted That Met QC Criteria
July 20, 2022
First Posted (Actual)
July 25, 2022
Study Record Updates
Last Update Posted (Actual)
April 2, 2026
Last Update Submitted That Met QC Criteria
March 31, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202206159
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingInjury, Spinal Cord
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
Institut GuttmannNot yet recruitingSpinal Cord Injury | Spinal Cord Disease | Spinal Cord Injuries (SCI) | Traumatic Spinal Cord InjuriesSpain
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Chang Gung Memorial HospitalNot yet recruitingSpine Injury | Complete Spinal Cord Injury | Incomplete Spinal Cord Injury | Cord Injury, Spinal | Cord Infarction Spinal
-
Kessler FoundationNot yet recruitingSpinal Cord Injury | Spinal Cord Disease | Spinal Cord Injuries (SCI)United States
Clinical Trials on Electrophysiology assessment - corticospinal tract
-
Washington University School of MedicineTerminated
-
Assiut UniversityNot yet recruitingMultiple Sclerosis
-
Shirley Ryan AbilityLabNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Mid-Atlantic...CompletedObesity | Opioid DependenceUnited States
-
EG 427Not yet recruitingUrinary Bladder, Overactive | Spinal Cord InjuryUnited States
-
Children's Oncology GroupRecruiting